组织纳米转移芯片和相关的基于电穿孔的技术用于体内组织重编程
Yi Xuan1, Cong Wang1, Subhadip Ghatak1
1McGowan Institute for Regenerative Medicine, Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA.
Nanomaterials (Basel, Switzerland)
|January 26, 2024
概括
组织纳米转移 (TNT) 提供了一个新的 in vivo 基因治疗方法. 这项技术为再生医学,伤口愈合和癌症治疗重新编程细胞,显示组织修复的希望.
科学领域:
- 生物技术是生物技术.
- 再生医学是一种再生医学.
- 基因治疗 基因治疗
背景情况:
- 组织纳米转移 (TNT) 是一种先进的体内基因治疗技术.
- 它将半导体技术与纳米电解和基于微针的透皮基因传递集成在一起.
- 在临床前研究中,TNT在组织重编程和修复方面显示出潜力.
研究的目的:
- 审查TNT芯片的设计,制造和应用.
- 分析TNT中基于电穿孔的基因转移机制.
- 讨论TNT在基因疗法和组织再生中的当前局限性和未来方向.
主要方法:
- 关于组织纳米转移的现有文献的综述.
- 对TNT的半导体芯片设计和制造的分析.
- 检查体内研究,证明TNT在细胞重编程和外体细胞追踪中的应用.
主要成果:
- 在体内,TNT芯片有效地将皮肤纤维细胞重编程成血管或神经细胞.
- 临床前研究表明,TNT在帮助受伤四肢和脑组织恢复方面具有实用性.
- 最近的应用扩展到追踪外体功能在伤口愈合.
结论:
- 在体内基因疗法和再生医学方面,TNT代表了重大进展.
- 该技术对各种治疗应用具有前景,包括组织修复和癌症治疗.
- 对TNT的局限性和机制的进一步研究将推动未来的基因治疗创新.
相关概念视频
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Introduction to Nuclear Reprogramming
1.9K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
1.9K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K


